Efficacy and Safety of Fasudil in Patients With Stable Angina
- 19 October 2005
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 46 (10) , 1803-1811
- https://doi.org/10.1016/j.jacc.2005.07.047
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaJournal of the American College of Cardiology, 2004
- Current Medical Management of Chronic Stable AnginaJournal of Cardiovascular Pharmacology and Therapeutics, 2004
- Assessment of absorption of RHO kinase inhibitor fasudil at different sites of the human gastrointestinal tractClinical Pharmacology & Therapeutics, 2004
- Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic AnginaA Randomized Controlled TrialJAMA, 2004
- Rho GTPases in cell biologyNature, 2002
- Dedicated Myosin Light Chain Kinases with Diverse Cellular FunctionsJournal of Biological Chemistry, 2001
- Inhibition of Myosin Phosphatase by Upregulated Rho-Kinase Plays a Key Role for Coronary Artery Spasm in a Porcine Model With Interleukin-1βCirculation, 2000
- Monitoring the quality of life in patients with coronary artery diseaseThe American Journal of Cardiology, 1994
- Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1992
- A comparison of nine calcium ion antagonists and propranolol: Exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectorisEuropean Journal of Clinical Pharmacology, 1987